{"id":46336,"date":"2022-07-19T18:01:55","date_gmt":"2022-07-19T16:01:55","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/"},"modified":"2022-07-19T18:01:55","modified_gmt":"2022-07-19T16:01:55","slug":"501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/","title":{"rendered":"$501 Billion Worldwide Biologics Industry to 2027 &#8211; Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5578085\/biologics-market-global-industry-trends-share?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=hzk7qq&amp;utm_campaign=1728447+-+%24501+Billion+Worldwide+Biologics+Industry+to+2027+-+Featuring+AbbVie%2C+Amgen%2C+AstraZeneca+and+Novartis+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220719005957\/en\/1517939\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220719005957\/en\/1517939\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global biologics market reached a value of US$ 294 billion in 2021. Looking forward, the market is projected to reach US$ 501.9 billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbVie Inc.\n<\/li>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nAstraZeneca plc\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd\n<\/li>\n<li>\nGlaxoSmithKline plc\n<\/li>\n<li>\nJohnson &amp; Johnson\n<\/li>\n<li>\nMerck KGaA\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nSanofi\n<\/li>\n<\/ul>\n<p>\nKeeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.\n<\/p>\n<p>\nBiologics, also known as biological drugs, are disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of components of living organisms. They include a wide variety of products, such as vaccines, blood, blood components, cells, genes, tissues, allergens, and recombinant proteins, derived from humans, animals, birds, insects, plants, and microorganisms.\n<\/p>\n<p>\nThese products control the production of vital proteins, modify human hormones and cells, while producing substances to activate and suppress the immune system. They also change the manner of operation of natural biologic intracellular and cellular actions. In recent years, biologics have gained immense traction as they are essentially utilized to treat various diseases and conditions, including Crohn&#8217;s disease, ulcerative colitis, rheumatoid arthritis and other autoimmune diseases.\n<\/p>\n<p>\nThe global biologics market is primarily driven by the rising incidences and diagnosis of chronic diseases that have necessitated the availability of advanced diagnostics and treatment drugs. Biologics are genetically engineered to target a specific part of the immune system that fuels inflammation. Governments of different countries are also taking initiatives to promote the healthcare sector and ensure the availability of biologics with the onset of coronavirus disease (COVID-19).\n<\/p>\n<p>\nFurthermore, scientists and researchers are extensively investigating species and expression systems to enhance the productivity of biological products. Moreover, various pharmaceutical companies are undertaking research and development (R&amp;D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn&#8217;s diseases.\n<\/p>\n<p>\n<strong>Key Questions Answered in This Report<\/strong>\n<\/p>\n<ul>\n<li>\nHow has the global biologics market performed so far and how will it perform in the coming years?\n<\/li>\n<li>\nWhat has been the impact of COVID-19 on the global biologics market?\n<\/li>\n<li>\nWhat are the key regional markets?\n<\/li>\n<li>\nWhat is the breakup of the market based on the source?\n<\/li>\n<li>\nWhat is the breakup of the market based on the product?\n<\/li>\n<li>\nWhat is the breakup of the market based on the disease?\n<\/li>\n<li>\nWhat is the breakup of the market based on the manufacturing?\n<\/li>\n<li>\nWhat are the various stages in the value chain of the industry?\n<\/li>\n<li>\nWhat are the key driving factors and challenges in the industry?\n<\/li>\n<li>\nWhat is the structure of the global biologics market and who are the key players?\n<\/li>\n<li>\nWhat is the degree of competition in the industry?\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Preface<\/strong>\n<\/p>\n<p>\n<strong>2 Scope and Methodology<\/strong>\n<\/p>\n<p>\n<strong>3 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4 Introduction<\/strong>\n<\/p>\n<p>\n4.1 Overview\n<\/p>\n<p>\n4.2 Key Industry Trends\n<\/p>\n<p>\n<strong>5 Global Biologics Market<\/strong>\n<\/p>\n<p>\n5.1 Market Overview\n<\/p>\n<p>\n5.2 Market Performance\n<\/p>\n<p>\n5.3 Impact of COVID-19\n<\/p>\n<p>\n5.4 Market Forecast\n<\/p>\n<p>\n<strong>6 Market Breakup by Source<\/strong>\n<\/p>\n<p>\n<strong>7 Market Breakup by Product<\/strong>\n<\/p>\n<p>\n<strong>8 Market Breakup by Disease<\/strong>\n<\/p>\n<p>\n<strong>9 Market Breakup by Manufacturing<\/strong>\n<\/p>\n<p>\n<strong>10 Market Breakup by Region<\/strong>\n<\/p>\n<p>\n<strong>11 SWOT Analysis<\/strong>\n<\/p>\n<p>\n<strong>12 Value Chain Analysis<\/strong>\n<\/p>\n<p>\n<strong>13 Porter&#8217;s Five Forces Analysis<\/strong>\n<\/p>\n<p>\n<strong>14 Price Analysis<\/strong>\n<\/p>\n<p>\n<strong>15 Competitive Landscape<\/strong>\n<\/p>\n<p>\n15.1 Market Structure\n<\/p>\n<p>\n15.2 Key Players\n<\/p>\n<p>\n15.3 Profiles of Key Players\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5578085\/biologics-market-global-industry-trends-share?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=hzk7qq&amp;utm_campaign=1728447+-+%24501+Billion+Worldwide+Biologics+Industry+to+2027+-+Featuring+AbbVie%2C+Amgen%2C+AstraZeneca+and+Novartis+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/9f0y2q<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x70;r&#101;&#115;&#x73;&#x40;r&#101;&#x73;&#x65;a&#114;&#x63;&#x68;a&#110;&#100;&#x6d;&#x61;r&#107;&#x65;&#x74;s&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#114;&#x65;&#x73;e&#97;&#x72;&#x63;h&#97;&#110;&#x64;&#x6d;a&#114;&#x6b;&#x65;t&#115;&#46;&#x63;&#x6f;m<\/a>\n<\/p>\n<p>\nFor E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global biologics market reached a value of US$ 294 billion in 2021. Looking forward, the market is projected to reach US$ 501.9 billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027. Companies &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46336","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$501 Billion Worldwide Biologics Industry to 2027 - Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$501 Billion Worldwide Biologics Industry to 2027 - Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global biologics market reached a value of US$ 294 billion in 2021. Looking forward, the market is projected to reach US$ 501.9 billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027. Companies ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-19T16:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220719005957\/en\/1517939\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"$501 Billion Worldwide Biologics Industry to 2027 &#8211; Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-19T16:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/\"},\"wordCount\":619,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719005957\\\/en\\\/1517939\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/\",\"name\":\"$501 Billion Worldwide Biologics Industry to 2027 - Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719005957\\\/en\\\/1517939\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-19T16:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719005957\\\/en\\\/1517939\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220719005957\\\/en\\\/1517939\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$501 Billion Worldwide Biologics Industry to 2027 &#8211; Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$501 Billion Worldwide Biologics Industry to 2027 - Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"$501 Billion Worldwide Biologics Industry to 2027 - Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global biologics market reached a value of US$ 294 billion in 2021. Looking forward, the market is projected to reach US$ 501.9 billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027. Companies ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-19T16:01:55+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220719005957\/en\/1517939\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"$501 Billion Worldwide Biologics Industry to 2027 &#8211; Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-07-19T16:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/"},"wordCount":619,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220719005957\/en\/1517939\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/","name":"$501 Billion Worldwide Biologics Industry to 2027 - Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220719005957\/en\/1517939\/21\/logo.jpg","datePublished":"2022-07-19T16:01:55+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220719005957\/en\/1517939\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220719005957\/en\/1517939\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/501-billion-worldwide-biologics-industry-to-2027-featuring-abbvie-amgen-astrazeneca-and-novartis-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"$501 Billion Worldwide Biologics Industry to 2027 &#8211; Featuring AbbVie, Amgen, AstraZeneca and Novartis Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46336"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46336\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}